Search Results - Kuznik A
- Showing 1 - 4 results of 4
-
1
Sarilumab monotherapy compared with adalimumab monotherapy for the treatment of moderately to severely active rheumatoid arthritis: an analysis of incremental cost per effectively... by Fournier M, Chen C, Kuznik A, Proudfoot C, Mallya UG, Michaud K
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Incremental Costs Associated with Length of Hospitalization Due to Viral Pneumonia: Impact of Intensive Care and Economic Implications of Reducing the Length of Stay in the Era of... by Wu N, Kuznik A, Wang D, Moretz C, Xi A, Kumar S, Hamilton L
Published 2020Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies by Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Budget impact analysis of sarilumab for the treatment of rheumatoid arthritis in patients with an inadequate response to conventional synthetic DMARD or TNF inhibitor therapies [Co... by Ferrufino CP, Munakata J, Wei W, Proudfoot C, Kuznik A, Boklage SH, Chen C
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book